Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Arun Kumar Singh & Rishabha Malviya. (2023) DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer
Vaccinations: Advancement and Developments. Current Gene Therapy 23:3, pages 170-183.
Crossref
Crossref
Si-Yuan Lu, Jie Hua, Jiang Liu, Miao-Yan Wei, Chen Liang, Qing-Cai Meng, Bo Zhang, Xian Jun Yu, Wei Wang & Jin Xu. (2022) Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. BMC Medical Genomics 15:1.
Crossref
Crossref
Yuhe Lei, Enxin Zhang, Liangliang Bai & Yingjie Li. (2022) Autophagy in Cancer Immunotherapy. Cells 11:19, pages 2996.
Crossref
Crossref
Xuan-Run Wang, Ze-Bo Jiang, Cong Xu, Wei-Yu Meng, Pei Liu, Yi-Zhong Zhang, Chun Xie, Jing-Yi Xu, Ya-Jia Xie, Tu-Liang Liang, Hao-Xin Yan, Xing-Xing Fan, Xiao-Jun Yao, Qi-Biao Wu & Elaine Lai-Han Leung. (2022) Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response. Pharmacological Research 179, pages 106198.
Crossref
Crossref
Qinghuan Kong, Xiaoyu Yan, Meiyu Cheng, Xin Jiang, Long Xu, Luyan Shen, Huimei Yu & Liankun Sun. (2022) p62 Promotes the Mitochondrial Localization of p53 through Its UBA Domain and Participates in Regulating the Sensitivity of Ovarian Cancer Cells to Cisplatin. International Journal of Molecular Sciences 23:6, pages 3290.
Crossref
Crossref
Silvina Odete Bustos, Fernanda Antunes, Maria Cristina Rangel & Roger Chammas. (2020) Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy. Frontiers in Oncology 10.
Crossref
Crossref
Lingzhi Xu, Fan Xu, Qingxia Kong, Ting Yang, Dewei Tan, Xiaoling Zhang, Na Li, Shanshan Zhao, Jinbo Zhao & Man Li. (2020) Inhibition of p62/SQSTM1 sensitizes small‐cell lung cancer cells to cisplatin‐induced cytotoxicity by targeting NEDD9 expression. Molecular Carcinogenesis 59:8, pages 967-979.
Crossref
Crossref
Dmitry M. Ponomarenko, Vladimir L. Gabai, Albert A. Sufianov, Sergey I. Kolesnikov & Alexander M. Shneider. (2020) Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy. Oncotarget 11:3, pages 294-299.
Crossref
Crossref
Guan-Min Jiang, Yuan Tan, Hao Wang, Liang Peng, Hong-Tao Chen, Xiao-Jun Meng, Ling-Ling Li, Yan Liu, Wen-Fang Li & Hong Shan. (2019) The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Molecular Cancer 18:1.
Crossref
Crossref
Franco M. Venanzi, Vladimir Gabai, Francesca Mariotti, Gian Enrico Magi, Cecilia Vullo, Albert A. Sufianov, Sergey I. Kolesnikov & Alexander Shneider. (2019) p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity. Aging 11:22, pages 10711-10722.
Crossref
Crossref
Nicholas Howard, Marco Clementino, Donghern Kim, Lei Wang, Angela Verma, Xianglin Shi, Zhuo Zhang & Robert S. DiPaola. (2019) New developments in mechanisms of prostate cancer progression. Seminars in Cancer Biology 57, pages 111-116.
Crossref
Crossref
Kira L. Russell, Carolina Mendonça Gorgulho, Abigail Allen, Marianna Vakaki, Yue Wang, Andrea Facciabene, Daniel Lee, Partha Roy, William J. Buchser, Leonard J. Appleman, Jodi Maranchie, Walter J. Storkus & Michael T. Lotze. (2019) Inhibiting Autophagy in Renal Cell Cancer and the Associated Tumor Endothelium. The Cancer Journal 25:3, pages 165-177.
Crossref
Crossref
Jinglu Wang, Cassandra Garbutt, Hangzhan Ma, Peng Gao, Francis J. Hornicek, Quancheng Kan, Huirong Shi & Zhenfeng Duan. (2018) Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer. Gynecologic Oncology 150:1, pages 143-150.
Crossref
Crossref
Lei Wang, Donghern Kim, James T.F. Wise, Xianglin Shi, Zhuo Zhang & Robert S. DiPaola. (2018) p62 as a therapeutic target for inhibition of autophagy in prostate cancer. The Prostate 78:5, pages 390-400.
Crossref
Crossref
Hangzhan Ma, Xiaoyang Li, Jinglu Wang, Francis J. Hornicek, Cassandra C. Garbutt, Xu Chang & Zhenfeng Duan. (2018) Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma. Oncology 95:1, pages 52-60.
Crossref
Crossref
Sizhe Yu, Yu Wang, Li Jing, F.X. Claret, Qing Li, Tao Tian, Xuan Liang, Zhiping Ruan, Lili Jiang, Yu Yao, Kejun Nan, Yi Lv & Hui Guo. (2017) Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy. Cancer Letters 411, pages 82-89.
Crossref
Crossref
Wen Xiao, Zhiyong Xiong, Changfei Yuan, Lin Bao, Di Liu, Xiong Yang, Wencheng Li, Junwei Tong, Yan Qu, Lei Liu, Haibing Xiao, Hongmei Yang, Xiaoping Zhang & Ke Chen. (2017) Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma. Oncotarget 8:55, pages 94819-94833.
Crossref
Crossref
Jian-Shu Lou, Wen-Chuan Bi, Gallant K.L. Chan, Yan Jin, Chau-Wing Wong, Zhong-Yu Zhou, Huai-You Wang, Ping Yao, Tina T.X. Dong & Karl W.K. Tsim. (2017) Ginkgetin induces autophagic cell death through p62/SQSTM1-mediated autolysosome formation and redox setting in non-small cell lung cancer. Oncotarget 8:54, pages 93131-93148.
Crossref
Crossref
Si-Si Li, Ling-Zhi Xu, Wei Zhou, Shang Yao, Chun-Li Wang, Jiang-Long Xia, He-Fei Wang, Muhammad Kamran, Xiao-Yuan Xue, Lin Dong, Jing Wang, Xu-Dong Ding, Laura Bella, Laurence Bugeon, Jie Xu, Fei-Meng Zheng, Margaret J Dallman, Eric W F Lam & Quentin Liu. (2017) p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Carcinogenesis 38:11, pages 1092-1103.
Crossref
Crossref
Tatiana Halenova, Oleksii Savchuk, Ludmila Ostapchenko, Andrey Chursov, Nathan Fridlyand, Andrey B. Komissarov, Franco Venanzi, Sergey I. Kolesnikov, Albert A. Sufianov, Michael Y. Sherman, Vladimir L. Gabai & Alexander M. Shneider. (2017) P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions. Oncotarget 8:34, pages 56030-56040.
Crossref
Crossref
Dmitry M. Ponomarenko, Irina D. Klimova, Yulia A. Chapygina, Viktoria V. Dvornichenko, Natalia V. Zhukova, Rashida V. Orlova, Georgy M. Manikhas, Alexandr V. Zyryanov, Lilya A. Burkhanova, Irina I. Badrtdinova, Basile N. Oshchepkov, Elena V. Filippova, Sergei V. Orlov, Sergei I. Kolesnikov, Albert A. Sufianov, Svetlana R. Baum, Olga Y. Zaitzeva, Andrey B. Komissarov, Mikhail P. Grudinin, Oleg I. Kiselev, Anatoly F. Tsyb, Franco Venanzi, Vita Shcherbinina, Andrey Chursov, Vladimir L. Gabai & Alexander M. Shneider. (2017) Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget 8:32, pages 53730-53739.
Crossref
Crossref
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa & Katerina Chlichlia. (2016) DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Pharmacology & Therapeutics 165, pages 32-49.
Crossref
Crossref
Koji Taniguchi, Shinichiro Yamachika, Feng He & Michael Karin. (2016) p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Letters 590:15, pages 2375-2397.
Crossref
Crossref
Hongming Pan, Liuxi Chen, Yinghua Xu, Weidong Han, Fang Lou, Weiqiang Fei, Shuiping Liu, Zhao Jing & Xinbing Sui. (2016) Autophagy-associated immune responses and cancer immunotherapy. Oncotarget 7:16, pages 21235-21246.
Crossref
Crossref
Jing Zhang, Zuozhang Yang & Jian Dong. (2016) P62: An emerging oncotarget for osteolytic metastasis. Journal of Bone Oncology 5:1, pages 30-37.
Crossref
Crossref
Maria Giovanna SabbietiDimitrios AgasMelania CapitaniLuigi MarchettiAntonio ConcettiCecilia VulloGiuseppe CatoneVladimir GabaiVictor ShifrinMichael Y ShermanAlexander ShneiderFranco M Venanzi. (2015) Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent. Oncotarget 6:6, pages 3590-3599.
Crossref
Crossref